Literature DB >> 16200634

Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil.

Mara A D Pianovski1, Eliane M C P Maluf, Denise S de Carvalho, Raul C Ribeiro, Carlos Rodriguez-Galindo, Paolo Boffetta, Patrícia Zancanella, Bonald C Figueiredo.   

Abstract

BACKGROUND: Several reports refer to an increased frequency of adrenal cortex tumors (ACT) among children in Southern Brazil, yet all data have been derived from hospital-based registries. An inherited germline mutation in the p53 gene (TP53 R337H) is detected in virtually all children with ACT in this region and accounts for the excess cases observed. PROCEDURE: We reviewed all death certificates that mentioned ACT or adrenal neuroblastoma (NB) and which were reported to the Paraná State Department of Health between 1998 and 2003, for individuals younger than 15 years who resided in the Curitiba metropolitan region.
RESULTS: Eight deaths from ACT and ten from NB were identified. The age-standardized mortality rate per million children <15 years of age in the Curitiba metropolitan region during the years 1998-2003 was 1.6 (95% confidence interval (CI) 1.4, 1.8) for ACT and 2.3 (95% CI 2.0, 2.5) for NB. The ratio of the adrenal NB and ACT age-adjusted mortality rates was 1.43. The incidence of ACT estimated from the mortality data, assuming an ACT survival rate of 0.542, was 3.5 (95% CI 2.9, 4.2).
CONCLUSIONS: Our investigation of population-based mortality confirms the evidence from hospital-based registries of a clustering of ACT in Southern Brazil. In addition, our data suggest that the incidence of ACT in this region is about 12-18 times the incidence reported in the United States and Europe. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16200634     DOI: 10.1002/pbc.20624

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  13 in total

1.  Management and prognosis of adrenocortical tumors in children: can we find out an appropriate points-scoring system to predict prognosis?

Authors:  Wei Ru; Min Yang; Shan Xu; Minju Li; Daxing Tang
Journal:  Pediatr Surg Int       Date:  2017-03-04       Impact factor: 1.827

Review 2.  Adrenocortical carcinoma: the management of metastatic disease.

Authors:  André P Fay; Aymen Elfiky; Gabriela H Teló; Rana R McKay; Marina Kaymakcalan; Paul L Nguyen; Anand Vaidya; Daniel T Ruan; Joaquim Bellmunt; Toni K Choueiri
Journal:  Crit Rev Oncol Hematol       Date:  2014-06-04       Impact factor: 6.312

Review 3.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

4.  Therapy of adrenocortical cancer: present and future.

Authors:  Daniela F Maluf; Brás H de Oliveira; Enzo Lalli
Journal:  Am J Cancer Res       Date:  2010-12-07       Impact factor: 6.166

Review 5.  Adrenocortical carcinoma: a clinician's update.

Authors:  Martin Fassnacht; Rossella Libé; Matthias Kroiss; Bruno Allolio
Journal:  Nat Rev Endocrinol       Date:  2011-03-08       Impact factor: 43.330

6.  TP53-Associated Pediatric Malignancies.

Authors:  Emilia M Pinto; Raul C Ribeiro; Bonald C Figueiredo; Gerard P Zambetti
Journal:  Genes Cancer       Date:  2011-04

7.  Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.

Authors:  Gislaine Custódio; Guilherme A Parise; Nilton Kiesel Filho; Heloisa Komechen; Cesar C Sabbaga; Roberto Rosati; Leila Grisa; Ivy Z S Parise; Mara A D Pianovski; Carmem M C M Fiori; Jorge A Ledesma; José Renato S Barbosa; Francisco R O Figueiredo; Elis R Sade; Humberto Ibañez; Sohaila B I Arram; Sérvio T Stinghen; Luciano R Mengarelli; Mirna M O Figueiredo; Danilo C Carvalho; Sylvio G A Avilla; Thiago D Woiski; Lisiane C Poncio; Geneci F R Lima; Roberto Pontarolo; Enzo Lalli; Yinmei Zhou; Gerard P Zambetti; Raul C Ribeiro; Bonald C Figueiredo
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544

8.  Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil.

Authors:  Gislaine Custodio; Guilherme R Taques; Bonald C Figueiredo; Elizabeth S Gugelmin; Mirna M Oliveira Figueiredo; Flora Watanabe; Roberto Pontarolo; Enzo Lalli; Luiz Fernando Bleggi Torres
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

9.  Impact of early postnatal androgen exposure on voice development.

Authors:  Leila Grisa; Maria L Leonel; Maria I R Gonçalves; Francisco Pletsch; Elis R Sade; Gislaine Custódio; Ivete P S Zagonel; Carlos A Longui; Bonald C Figueiredo
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

10.  Identity by descent mapping of founder mutations in cancer using high-resolution tumor SNP data.

Authors:  Eric Letouzé; Aliou Sow; Fabien Petel; Roberto Rosati; Bonald C Figueiredo; Nelly Burnichon; Anne-Paule Gimenez-Roqueplo; Enzo Lalli; Aurélien de Reyniès
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.